APA aipamena

Morvan, F., Rondeau, J., Zou, C., Minetti, G., Scheufler, C., Scharenberg, M., . . . Lach-Trifilieff, E. (2017). Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy. Proc Natl Acad Sci U S A.

Chicago Style aipamena

Morvan, Frederic, et al. "Blockade of Activin Type II Receptors With a Dual Anti-ActRIIA/IIB Antibody Is Critical to Promote Maximal Skeletal Muscle Hypertrophy." Proc Natl Acad Sci U S A 2017.

MLA aipamena

Morvan, Frederic, et al. "Blockade of Activin Type II Receptors With a Dual Anti-ActRIIA/IIB Antibody Is Critical to Promote Maximal Skeletal Muscle Hypertrophy." Proc Natl Acad Sci U S A 2017.